CUDC-907 mesylate is a small molecule inhibitor of histone deacetylase and PI3 kinase developed by Curis. It is investigated in clinical trials for the treatment of relapsed or refractory lymphomas, thyroid cancer, multiple myeloma, breast cancer and other malignancies.
Molekulargewicht:
604.66
CAS Nummer:
[1401998-36-4]
Formel:
C24H28N8O7S2
Target-Kategorie:
Others|||HDAC|||PI3K|||Apoptosis
T70759
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten